Sionna Therapeutics Inc’s filing revealed that its 10% Owner TPG GP A, LLC acquired Company’s shares for reported $20.25 million on Feb 10 ’25. In the deal valued at $18.00 per share,1,125,000 shares were bought. As a result of this transaction, TPG GP A, LLC now holds 6,684,962 shares worth roughly $105.89 million.
Then, RA CAPITAL MANAGEMENT, L.P. bought 1,125,000 shares, generating $20,250,000 in total proceeds. Upon buying the shares at $18.00, the Director now owns 6,923,365 shares.
Before that, ORBIMED ADVISORS LLC bought 550,000 shares. Sionna Therapeutics Inc shares valued at $9,900,000 were divested by the Director at a price of $18.00 per share. As a result of the transaction, ORBIMED ADVISORS LLC now holds 3,704,959 shares, worth roughly $58.69 million.
TD Cowen initiated its Sionna Therapeutics Inc [SION] rating to a Buy in a research note published recently. A number of analysts have revised their coverage, including Stifel’s analysts, who began to cover the stock in early March with a ‘”a Buy”‘ rating. Guggenheim began covering SION with “Buy” recommendation on March 04, 2025.
Price Performance Review of SION
On Friday, Sionna Therapeutics Inc [NASDAQ:SION] saw its stock jump 6.81% to $15.84. Over the last five days, the stock has gained 9.32%. Nevertheless, the stocks have fallen -36.64% over the past one year.
Levels Of Support And Resistance For SION Stock
The 24-hour chart illustrates a support level at 15.02, which if violated will result in even more drops to 14.20. On the upside, there is a resistance level at 16.31. A further resistance level may holdings at 16.78.
How much short interest is there in Sionna Therapeutics Inc?
A steep rise in short interest was recorded in Sionna Therapeutics Inc stocks on 2025-06-13, growing by 0.24 million shares to a total of 2.83 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 2.59 million shares. There was a rise of 8.49%, which implies that there is a positive sentiment for the stock.
